Clinical Trial Update: OSI-7904L and Oxaliplatin in Treating Patients With Refractory or Recurrent Advanced Colorectal Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating OSI-7904L in combination with oxaliplatin for patients with refractory or recurrent advanced colorectal cancer. The trial has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• OSI-7904L (OSI-7904L)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Colorectal Cancer | Phase 1 | Status: COMPLETED